Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked

Emma Cauzzi1, Serena Ficchì1, Maria Luisa De Paolis2

  • 1Department of Medicine, Surgery and Dentistry, Università Campus Bio-Medico di Roma, 00128 Roma, Italy.

Insights

Midbrain dopamine loss destabilizes hippocampal circuits by degrading perineuronal nets, leading to progressive neuron loss. Restoring dopamine D2/D3 receptor signaling protects these nets and circuit function in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Neurodegenerative Diseases

Background:

  • Midbrain dopaminergic degeneration is an early feature of Alzheimer's Disease (AD), dementia with Lewy bodies (DLB), and AD-Parkinson's disease overlap (AD-PD).
  • Parvalbumin-positive interneurons (PV-INs) are crucial for hippocampal excitation-inhibition balance and are modulated by dopamine (DA).
  • Perineuronal nets (PNNs) protect PV-INs, supporting GABAergic signaling and neuronal resilience.

Purpose of the Study:

  • To investigate if midbrain-derived DA loss is sufficient to destabilize hippocampal PV-IN function and PNN integrity.
  • To explore the role of the DA-D2/D3R-tPA axis in maintaining PV-IN extracellular-matrix integrity.
  • To identify potential therapeutic targets for stabilizing hippocampal circuits in AD, DLB, and AD-PD.

Main Methods:

  • Stereotaxic unilateral 6-hydroxy-dopamine lesion of the Ventral Tegmental Area/Substantia Nigra pars compacta in mice to reduce hippocampal DA tone.
  • Assessment of PV-IN numbers, PNN integrity, and tissue plasminogen activator (tPA) expression at 1 and 6 months post-lesion.
  • Electrophysiological recordings of inhibitory postsynaptic currents and neuronal excitability in CA1 pyramidal neurons.
  • Pharmacological interventions using D2/D3 receptor (D2/D3R) agonist quinpirole.

Main Results:

  • DA depletion led to reduced PNN integrity and increased tPA expression by 1 month, without altering PV-IN numbers.
  • CA1 pyramidal neurons exhibited reduced inhibitory postsynaptic current frequency and faster decay, with heightened excitability.
  • By 6 months, a significant decline in PV-IN numbers was observed, particularly in CA1.
  • D2/D3R activation normalized tPA levels, restored PNN integrity, and increased inhibitory postsynaptic event frequency, indicating functional recovery.

Conclusions:

  • Midbrain DA depletion is sufficient to destabilize hippocampal PV-INs, disrupt PNN integrity, reduce GABAergic inhibition, and cause progressive PV-IN loss.
  • A DA-D2/D3R-tPA axis is involved in maintaining PV-IN extracellular-matrix integrity and hippocampal inhibitory tone.
  • This mechanism links midbrain degeneration to hippocampal circuit failure, independent of canonical AD pathologies.
  • D2/D3R signaling and extracellular proteolysis represent actionable targets for early circuit stabilization in AD, DLB, and AD-PD.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...